未登录

W

Wei-Hwa Lee

Taipei Medical University-Shuang Ho Hospital

H指数:34

被引数:3,807

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Bamodu et al. 4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 Re-Expression. Cancers 2018, 10, 269

更正：Bamodu等人. 4-乙酰基-安托喹诺醇B通过诱导hsa-miR-324再表达抑制SOD2增强的结肠癌细胞干性表型和化疗耐药性。Cancers 2018, 10, 269

Cancers 2025, Vol. 17, Page 3304

IF0

2025-10-130

OAAI

Notopterol mitigates IL-1β-triggered pyroptosis by blocking NLRP3 inflammasome via the JAK2/NF-kB/hsa-miR-4282 route in osteoarthritis

在骨关节炎中，Notopterol通过JAK2/nf-kb/hsa-miR-4282途径阻断NLRP3炎性体来减轻il-1β 触发的焦亡

IF3.6

2024-03-014

OAAI

The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p

IF3.6

2021-10-0125

PREAI

Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling

PHARMACEUTICALS

IF4.8

2021-08-2913

OAAI

Inhibition of Bruton's tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness

IF6.4

2021-02-2721

OAAI

SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma

IF5.2

2021-01-1725

OAAI

Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma

靶向表观遗传非编码RNA MALAT1/Wnt信号轴作为抑制肝细胞癌干性和转移的治疗方法

IF5.2

2020-04-2024

OAAI

Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer

IF5.2

2020-04-0812

OAAI

Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma

IF5.2

2020-03-18119

OAAI

Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma

IF5.2

2019-12-1821

OAAI

Novel multi-drugs incorporating hybrid-structured nanofibers enhance alkylating agent activity in malignant gliomas

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2019-09-265

OAAI

Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathway

IF8.3

2019-03-0139

PREAI

The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (vol 35, pg 663, 2018)

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2019-01-042

OAAI

DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-11-2128

OAAI

Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation

IF7.3

2018-10-2228

PREAI

HDAC inhibitor suppresses proliferation and tumorigenicity of drug resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

EXPERIMENTAL CELL RESEARCH

IF3.5

2018-09-0129

PREAI

Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor

CLINICAL EPIGENETICS

IF4.4

2018-08-0953

OAAI

The therapeutic targeting of the FGFR1/Src/NF-B signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2018-07-0925

PREAI

4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2017-06-0140

PREAI

Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2017-02-0122

OAAI